Spain's Grifols H1 net profit up 37 pct

MADRID, July 31 Wed Jul 31, 2013 2:45am EDT

Related Topics

MADRID, July 31 (Reuters) - Spanish pharmaceutical company Grifols, the world's third-largest blood products maker, said on Wednesday net profit rose 37 percent in the first half from a year earlier to 182.8 million euros ($242 million), boosted by overseas sales, especially in the United States.

Barcelona-based Grifols, which generates over 90 percent of its sales outside its recession-hit home market, said first half revenue was 1.38 billion euros, up 4.9 percent from the same period last year. ($1 = 0.7547 euros) (Reporting by Julien Toyer; Editing by Sonya Dowsett)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.